Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I guess we know what Bjorn’s plan was now
“If the Court accepts our bid as the winning offer, Sonendo is committed to ensuring a smooth transition that delivers a continuity of support and service to all Biolase customers and their patients, as well as their suppliers and other vendors,” said Bjarne Bergheim, President and Chief Executive Officer of Sonendo. “The Sonendo team is very enthusiastic about the prospect of bringing these two organizations together. We anticipate meaningful cross-selling and significant cost reduction synergy opportunities as a combined company and that we will emerge as a stronger organization that can leverage a more comprehensive technology platform through increasingly focused specialty sales organizations to help advance our mission of saving teeth and restoring health.”
$SONX - Sonendo executes asset purchase agreement to acquire Biolase assets https://t.co/eXeNL5MRVt
— Seeking Alpha Market News (@MarketCurrents) October 9, 2024
Yeah if the otc as a whole gets some money flowing into it, that will help too
I gave him the name of a small start up but he poo pooed it
Lithium was FUNR
The news would have to be heart pounding
Biol consistently has the best dental lasers on the market, it will be a good pickup for SONX
Best Dental Lasers for sale in 2024
BIOLASE Epic. Average price:
BIOLASE Waterlase MD.
BIOLASE Waterlase C100. Average price:
LAMBDA S.P.A Doctor Smile Pluser. Average price:
BIOLASE Waterlase iPlus.
MEDENCY Primo Lite.
HOYA CONBIO VersaWave.
OSAKA Dental Laser 7 Watt. Average price:
Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
May hit 6 cents plus with the trading pattern today
Yes I agree
Seems investors are not convinced yet
It’s been pathetic! Hoping for one last hooray and I’m done with the otc
From what the 8k says it’s an asset purchase not a merger tho
Well sure there is always a long picture but I believe we will get a pop over 10 to 20 cents in the short term with any good news that comes out of this. It gives those who have been here from the delisting to recoup or those who bought at 2.5 cents to make a nice profit.
Long term, yes who knows.
There are analysts eyes still on this
https://www.tradingview.com/news/zacks:a52b18b00094b:0-here-s-why-sonendo-sonx-is-a-great-buy-the-bottom-stock-now/
If things go their way with BIOLASE and the bankruptcy I can see the stock responding with a pop in the short term
This last half of 2024 could be what we’ve all been waiting for.
In spite of what happened to the stock. They are worth a lot more than 5 cents.
CEO just needs to put out some good news and perhaps pump a bit.
One year of cuts and saving money will show and is showing too
Yeah the RS is always a problem. I’m hoping they get the price over ten cents and stay there talking that out of the equation to stay OTCQX
Rich, what do you think is CEO’S plan with BIOLASE? He bought the other laser company pepstek and shelved it. It’s hard to believe that he does that with BIOLASE seeing they have other applications other than root canal. He said he wanted to get into cavity treatment and preventative also.
Hard to imagine he passes on the $50 million in revenue biol brings
Yes all scenarios are possible
Autumn through spring is usually good for the OTC.
Hopefully we get a run on otc which will be real good timing for us
Looks like the sale of the software division for $15 million will pay for this purchase of assets from BIOLASE
What’s the viewpoint on the hold up here?
Sure, I would say that’s a very possible. I think yahoo has a target of $.25 right now.
True that is saying those websites are correct. Right now I will be happy with 50000,000 lol
I think this could get to 15 $.20 and stay there very easily based on revenue and market cap and potential deal with BIOL
they do $50 million a year.
BIOLASE laser does dermatology work too.
They do alot more than SONX. It will be a good blend
https://www.biolase.com/
If this is big as we think it is meaning market cap and revenue this could be the biggest merger that the OTC has had maybe ever
Our portfolio includes some of the most renowned dental laser products in the industry, and we are eager to partner with Sonendo, leveraging their extensive expertise in the dental sector to continue advancing our mission
https://www.dentistryiq.com/dentistry/research-and-news/article/55193337/biolase-files-for-bankruptcy-under-chapter-11-proceedings-sonendo-set-to-acquire-assets
Not yet, still just an agreement I think
Not final
Yeah true but up from 2.5 cents lol
Zacks has a buy rating
https://www.zacks.com/stock/quote/SONX
Under the agreement, Sonendo will acquire substantially all of the assets of BIOLASE through a Court-supervised auction process, subject to Bankruptcy Court approval and certain other conditions, for (a) $14.0 million in cash paid at closing, subject to a working capital adjustment; plus (b) assumption of certain Assumed Liabilities (as defined in the Asset Purchase Agreement); plus (c) the Delaware Litigation Settlement Value (as defined in the Asset Purchase Agreement). This bid will serve as a starting point for the Company's sale process, which may include other bidders. Sonendo is a leading dental technology company.
BIOLASE CEO John Beaver commented, "After carefully considering a range of alternatives, we are confident that pursuing Chapter 11 provides the most viable long-term path for BIOLASE to address its liquidity challenges. Our portfolio includes some of the most renowned dental laser products in the industry, and we are eager to partner with Sonendo, leveraging their extensive expertise in the dental sector to continue advancing our mission. We deeply appreciate the ongoing support from our customers and suppliers throughout this process, and we also want to recognize the dedication of our talented employees."
It’s been unbelievable how they have been able to hold this down
#Dental laser company Biolase and its subsidiaries voluntarily filed on October 1 for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware and plans to sell its assets for $14 million to competitor Sonendo... https://t.co/NddSr5Hn0x
— DrBicuspid (@drbicuspid) October 2, 2024
And just certain assets would be purchased while they pursue bankruptcy
I think it’s not a done deal. Just an agreement in place
On September 30, 2024, Sonendo, Inc., a Delaware corporation (the “Company”), entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with Biolase, Inc., a Delaware corporation (“Biolase”), BL Acquisition Corp., a Delaware corporation (“BL Acquisition”), BL Acquisition II, Inc., a Delaware corporation (“BL Acquisition II”), and Model Dental Office, LLC, a Delaware limited liability company (“MDO” and together with Biolase, BL Acquisition and BL Acquisition II, each a “Seller” and collectively, the “Sellers”), pursuant to which, subject to the terms and conditions set forth in the Asset Purchase Agreement, the Company agreed to acquire certain assets of the Sellers and their subsidiaries on an as-is, where-is basis, including specified inventory, intellectual property and intellectual property rights, products, contracts, equipment and other personal property, records, and intangibles related to the business of developing, manufacturing, marketing and selling dental laser systems, all tissue lasers, soft tissue lasers and other medical devices, as conducted by the Sellers and their subsidiaries (collectively, the “Assets”), and assume certain specified liabilities of the Sellers and their subsidiaries (collectively, the “Liabilities” and such acquisition of the Assets and assumption of the Liabilities together, the “Transaction”) for a total purchase price of (i) $14 million in cash subject to a downward working capital adjustment, (ii) the assumption of liabilities and (iii) the value of the Delaware Litigation (as defined in the Asset Purchase Agreement) (the “Purchase Price”). The Company will deliver 10% of the Purchase Price to an escrow agent, which may be returned to the Company in the event of specified events, including termination of the Asset Purchase Agreement, subject to certain exceptions relating to a breach of the Asset Purchase Agreement by the Company.
8 k out explaining more about the asset purchase agreement with biolase
https://fintel.io/doc/sec-sonendo-inc-1407973-8k-2024-october-02-19998-344?utm_source=twitter.com&utm_medium=referral&utm_campaign=filing
Almost as good as your POS CBDD YES LOL
I think he just may not know what to do with it at this point. Interest rates went up and without a good merger candidate it’s hopeless. As interest rates come down we stand a better chance imo